99 related articles for article (PubMed ID: 22905195)
1. Tyrosinase degradation is prevented when EDEM1 lacks the intrinsically disordered region.
Marin MB; Ghenea S; Spiridon LN; Chiritoiu GN; Petrescu AJ; Petrescu SM
PLoS One; 2012; 7(8):e42998. PubMed ID: 22905195
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum degradation-enhancing α-mannosidase-like protein 1 targets misfolded HLA-B27 dimers for endoplasmic reticulum-associated degradation.
Guiliano DB; Fussell H; Lenart I; Tsao E; Nesbeth D; Fletcher AJ; Campbell EC; Yousaf N; Williams S; Santos S; Cameron A; Towers GJ; Kellam P; Hebert DN; Gould KG; Powis SJ; Antoniou AN
Arthritis Rheumatol; 2014 Nov; 66(11):2976-88. PubMed ID: 25132672
[TBL] [Abstract][Full Text] [Related]
3. Basal autophagy is involved in the degradation of the ERAD component EDEM1.
Le Fourn V; Gaplovska-Kysela K; Guhl B; Santimaria R; Zuber C; Roth J
Cell Mol Life Sci; 2009 Apr; 66(8):1434-45. PubMed ID: 19266160
[TBL] [Abstract][Full Text] [Related]
4. Identification of EGF Receptor and Thrombospondin-1 as Endogenous Targets of ER-Associated Degradation Enhancer EDEM1 in HeLa Cells.
Miura K; Katsuki R; Yoshida S; Ohta R; Tamura T
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569550
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence monitoring of refluxed tyrosinase using endoplasmic reticulum-localized enzymatic activity-based sensing.
Shu D; Xie W; Liu H; Li J; Jiao J; Mao G; Yang S; Zhang K
Chem Commun (Camb); 2024 May; 60(43):5618-5621. PubMed ID: 38713525
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis and functional evaluation of the disordered ß-hexosyltransferase region from
Dagher SF; Vaishnav A; Stanley CB; Meilleur F; Edwards BFP; Bruno-Bárcena JM
Front Bioeng Biotechnol; 2023; 11():1291245. PubMed ID: 38162180
[No Abstract] [Full Text] [Related]
7. Targeting EDEM protects against ER stress and improves development and survival in C. elegans.
Ghenea S; Chiritoiu M; Tacutu R; Miranda-Vizuete A; Petrescu SM
PLoS Genet; 2022 Feb; 18(2):e1010069. PubMed ID: 35192599
[TBL] [Abstract][Full Text] [Related]
8. EDEM1 Regulates Amyloid Precursor Protein (APP) Metabolism and Amyloid-β Production.
Nowakowska-Gołacka J; Czapiewska J; Sominka H; Sowa-Rogozińska N; Słomińska-Wojewódzka M
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008544
[TBL] [Abstract][Full Text] [Related]
9. EDEM3 Domains Cooperate to Perform Its Overall Cell Functioning.
Manica G; Ghenea S; Munteanu CVA; Martin EC; Butnaru C; Surleac M; Chiritoiu GN; Alexandru PR; Petrescu AJ; Petrescu SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671632
[TBL] [Abstract][Full Text] [Related]
10. The Crucial Role of Demannosylating Asparagine-Linked Glycans in ERADicating Misfolded Glycoproteins in the Endoplasmic Reticulum.
Zhang J; Wu J; Liu L; Li J
Front Plant Sci; 2020; 11():625033. PubMed ID: 33510762
[TBL] [Abstract][Full Text] [Related]
11. Clamping, bending, and twisting inter-domain motions in the misfold-recognizing portion of UDP-glucose: Glycoprotein glucosyltransferase.
Modenutti CP; Blanco Capurro JI; Ibba R; Alonzi DS; Song MN; Vasiljević S; Kumar A; Chandran AV; Tax G; Marti L; Hill JC; Lia A; Hensen M; Waksman T; Rushton J; Rubichi S; Santino A; Martí MA; Zitzmann N; Roversi P
Structure; 2021 Apr; 29(4):357-370.e9. PubMed ID: 33352114
[TBL] [Abstract][Full Text] [Related]
12. Oxidoreductases in Glycoprotein Glycosylation, Folding, and ERAD.
Patel C; Saad H; Shenkman M; Lederkremer GZ
Cells; 2020 Sep; 9(9):. PubMed ID: 32971745
[TBL] [Abstract][Full Text] [Related]
13. EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.
Chiritoiu M; Chiritoiu GN; Munteanu CVA; Pastrama F; Ivessa NE; Petrescu SM
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423001
[TBL] [Abstract][Full Text] [Related]
14. Genome-Wide Analysis of Whole Human Glycoside Hydrolases by Data-Driven Analysis in Silico.
Nakamura T; Fahmi M; Tanaka J; Seki K; Kubota Y; Ito M
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847093
[TBL] [Abstract][Full Text] [Related]
15. Modulation of ERQC and ERAD: A Broad-Spectrum Spanner in the Works of Cancer Cells?
Tax G; Lia A; Santino A; Roversi P
J Oncol; 2019; 2019():8384913. PubMed ID: 31662755
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide functional analyses of plant coiled-coil NLR-type pathogen receptors reveal essential roles of their N-terminal domain in oligomerization, networking, and immunity.
Wróblewski T; Spiridon L; Martin EC; Petrescu AJ; Cavanaugh K; Truco MJ; Xu H; Gozdowski D; Pawłowski K; Michelmore RW; Takken FLW
PLoS Biol; 2018 Dec; 16(12):e2005821. PubMed ID: 30540748
[TBL] [Abstract][Full Text] [Related]
17. Mannosidase activity of EDEM1 and EDEM2 depends on an unfolded state of their glycoprotein substrates.
Shenkman M; Ron E; Yehuda R; Benyair R; Khalaila I; Lederkremer GZ
Commun Biol; 2018; 1():172. PubMed ID: 30374462
[TBL] [Abstract][Full Text] [Related]
18. EDEM1's mannosidase-like domain binds ERAD client proteins in a redox-sensitive manner and possesses catalytic activity.
Lamriben L; Oster ME; Tamura T; Tian W; Yang Z; Clausen H; Hebert DN
J Biol Chem; 2018 Sep; 293(36):13932-13945. PubMed ID: 30021839
[TBL] [Abstract][Full Text] [Related]
19. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
[TBL] [Abstract][Full Text] [Related]
20. Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.
Vitiello M; Tuccoli A; D'Aurizio R; Sarti S; Giannecchini L; Lubrano S; Marranci A; Evangelista M; Peppicelli S; Ippolito C; Barravecchia I; Guzzolino E; Montagnani V; Gowen M; Mercoledi E; Mercatanti A; Comelli L; Gurrieri S; Wu LW; Ope O; Flaherty K; Boland GM; Hammond MR; Kwong L; Chiariello M; Stecca B; Zhang G; Salvetti A; Angeloni D; Pitto L; Calorini L; Chiorino G; Pellegrini M; Herlyn M; Osman I; Poliseno L
Oncotarget; 2017 Apr; 8(15):25395-25417. PubMed ID: 28445987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]